Role of myeloperoxidase in atrial fibrillation and ischemic heart disease

Role of myeloperoxidase in atrial fibrillation and ischemic heart disease

Atrial fibrillation and ischemic heart disease are the key problems in cardiology. Despite of numerous clinical trials and researches underlying molecular biology remains uncertain. Atrial fibrillation and ischemic heart disease are often combined. During ischemic heart disease progression myocardia...

Full description

Saved in:

Bibliographic Details
Main Authors:	G. F. Bunenkova, S. P. Salikova, V. B. Grinevich, E. S. Ivanyuk
Format:	Article
Language:	Russian
Published:	ABV-press 2023-01-01
Series:	Klinicist
Subjects:	atrial fibrillation ischemic heart disease atherosclerosis myeloperoxidase oxidative stress chronic inflammation neutrophils hypochlorous acid matrix metalloproteinases pathogenesis
Online Access:	https://klinitsist.abvpress.ru/Klin/article/view/507
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Myeloperoxidase enzyme-catalyzed breakdown of zero-dimension carbon quantum dots
by: Pooja Singh, et al.
Published: (2024-11-01)

Myeloperoxidase as a therapeutic target for oxidative damage in Alzheimer’s disease
by: Astrid Mayleth Rivera Antonio, et al.
Published: (2025-12-01)

Histones in neutrophil extracellular traps (NETs) contain oxidative post-translational modifications induced by the myeloperoxidase oxidant hypochlorous acid
by: Helen Hemmling, et al.
Published: (2025-07-01)

Ischemic Stroke in Patients With Congenital Heart Disease and Atrial Fibrillation
by: Arvid Holmgren, et al.
Published: (2024-09-01)

Features of the arterial hypertension clinical course in patients with ischemic heart disease and atrial fibrillation.
by: M. I. Yalovenko, et al.
Published: (2019-01-01)

Interactions between atrial fibrosis and inflammation in atrial fibrillation
by: Zhihua Pang, et al.
Published: (2025-07-01)

THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

PHARMACODYNAMICS OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ACUTE PERIOD OF ISCHEMIC STROKE
by: V. I. Petrov, et al.
Published: (2021-01-01)

Association Between Age at Diagnosis of Atrial Fibrillation and Subsequent Risk of Ischemic Stroke
by: Yun‐Jiu Cheng, et al.
Published: (2025-02-01)

Pericardial Fluid Biomarkers as Early Predictors for Postoperative Atrial Fibrillation—A Systematic Review
by: Florin Mitu, et al.
Published: (2025-02-01)

Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
by: A. O. Rubanenko, et al.
Published: (2018-11-01)

ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION
by: A. N. Zakirova, et al.
Published: (2015-09-01)

Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease
by: O. A. Rubanenko
Published: (2015-11-01)

Antithrombotic agents and effect on outcomes in ischemic stroke with atrial fibrillation and large artery atherosclerosis: a real-world study
by: Jilu Chen, et al.
Published: (2025-06-01)

CLINICAL-GENETIC RISKOMETER FOR THE ISCHEMIC STROKE RISK ASSESSMENT IN ATRIAL FIBRILLATION
by: N. V. Aksyutina, et al.
Published: (2015-10-01)

Pathogenesis and clinical significance of atrial fibrillation in myocardial infarction
by: M. V. Zykov, et al.
Published: (2021-03-01)

The role of inflammatory markers in atrial fibrillation: a review
by: S. V. Grigoryan, et al.
Published: (2012-10-01)

Approaches to anticoagulation therapy selection in patients with non-valvular atrial fibrillation and ischemic heart disease
by: N. A. Koziolova, et al.
Published: (2016-04-01)

Anti-inflammatory and antiresorptive effects of acyl substitution chromone derivatives in experimental model of rheumatoid arthritis
by: D. I. Pozdnyakov, et al.
Published: (2024-01-01)

Biomarkers of cellular senescence predict risk of mild cognitive impairment: Results from the lifestyle interventions for elders (LIFE) study
by: Michelle M. Mielke, et al.
Published: (2025-05-01)

Prevalence of atrial fibrillation in ischemic stroke and associated risk factors: A hospital-based study in Indonesia
by: Theodore Amadeo Nathan, et al.
Published: (2024-12-01)

HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. V. Moiseev
Published: (2015-12-01)

Polypharmacy in atrial fibrillation: A prospective analysis of mortality and ischemic stroke using the Clinical Practice Research Datalink
by: Natasha Slater, et al.
Published: (2024-02-01)

Pathogenic Mechanisms of Atrial Fibrillation in Obesity
by: O. M. Drapkina, et al.
Published: (2016-11-01)

The Risk of Ischemic Stroke in Patients with Chronic Obstructive Pulmonary Disease and Atrial Fibrillation
by: Hsien-Lung Tsai, et al.
Published: (2025-01-01)

CHA2DS2-VASc Score Is Associated With Prognosis in Patients With Acute Ischemic Stroke Without Atrial Fibrillation
by: Mingjuan Song, MM, et al.
Published: (2025-02-01)

Sex Differences and 2‐Year Mortality in Patients With Atrial Fibrillation Diagnosed After Stroke and Known Atrial Fibrillation: A Register‐Based Study in Sweden
by: Ilham Al Khatib, et al.
Published: (2025-04-01)

Comprehensive bioinformatics analysis of hub genes in ischemic heart failure and atrial fibrillation
by: Meimei Zhou, et al.
Published: (2025-02-01)

THE COMPARISON OF ARRHYTHMOGENICITY OF DIFFERENT SURGICAL APPROACHES TO ATRIAL FIBRILLATION IN PATIENTS WITH CORONARY HEART DISEASE
by: A. M. Chernyavsky, et al.
Published: (2014-04-01)

Interplay of Heat Shock Proteins and Oxidative Stress in Modulating Neutrophil Activation in Cystic Fibrosis Inflammation
by: Arif Malik, et al.
Published: (2025-04-01)

Role of the autonomic nervous system in atrial fibrillation pathogenesis
by: E. P. Popova, et al.
Published: (2020-08-01)

Anticoagulant therapy in patients with cardioembolic subtype of ischemic stroke and atrial fibrillation
by: E. A. Naryshkina, et al.
Published: (2025-06-01)

Retinal Ischemic Perivascular Lesions Are Associated With Stroke in Individuals With Atrial Fibrillation
by: Christine Y. Bakhoum, et al.
Published: (2024-09-01)

Estimation of myeloperoxidase levels in smokers, pan chewers, and normal individuals using enzyme-linked immunosorbent assay: An observational study
by: Meyyappan Arunachalam, et al.
Published: (2024-01-01)

Assessment of Inflammatory Biomarkers and Incident Atrial Fibrillation in Older Adults
by: Sanyog G. Shitole, et al.
Published: (2024-12-01)

Determining Differences in the Association Between Atrial Fibrillation and Ischemic Stroke Outcomes by Treatment Received
by: Ana Lopez, et al.
Published: (2024-10-01)

A predictive score for atrial fibrillation in poststroke patients
by: Caroliny Trevisan Teixeira, et al.
Published: (2024-10-01)

PATIENTS WITH ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOSPITALIZATION STRUCTURE AND ANTITHROMBOTIC THERAPY (RECVASA AF-KURSK REGISTRY)
by: V. P. Mikhin, et al.
Published: (2017-05-01)

Comprehensive bioinformatics analysis of the common mechanism of atherosclerosis and atrial fibrillation: emphasizing mitochondrial metabolic disorder and immune inflammation
by: Rui Dai, et al.
Published: (2025-06-01)

The Role of Atrial Fibrillation and Oral Anticoagulation Status in Health‐Related Quality of Life 12 Months After Ischemic Stroke or TIA
by: Manuel C. Olma, et al.
Published: (2025-01-01)